Deborah Morosini

Activation of MET via Diverse Exon 14 Splicing Alterations Occurs in Multiple Tumor Types and Confers Clinical Sensitivity to MET Inhibitors

Garrett M. Frampton, Siraj M. Ali, Mark R. Rosenzweig et al. · Cancer Discovery · 2015 · 796 citations · Full text

Medicine, Molecular Genetics, Oncology +16

The JAK2 Inhibitor AZD1480 Potently Blocks Stat3 Signaling and Oncogenesis in Solid Tumors

Michael Hedvat, Dennis Huszar, Andreas Herrmann et al. · Cancer Cell · 2009 · 529 citations · Full text

Medicine, Oncology, Pharmacology +9

New Routes to Targeted Therapy of Intrahepatic Cholangiocarcinomas Revealed by Next-Generation Sequencing

Jeffrey S. Ross, Kai Wang, Laurie M. Gay et al. · The Oncologist · 2014 · 462 citations · Full text

Medicine, Genetics, Oncology +17

An Oncogenic <i>NTRK</i> Fusion in a Patient with Soft-Tissue Sarcoma with Response to the Tropomyosin-Related Kinase Inhibitor LOXO-101

Robert C. Doebele, Lara E. Davis, Aria Vaishnavi et al. · Cancer Discovery · 2015 · 387 citations · Full text

Medicine, Cancer Biology, Oncology +17

Integrated genomic DNA/RNA profiling of hematologic malignancies in the clinical setting

Jie He, Omar Abdel‐Wahab, Michelle Nahas et al. · Blood · 2016 · 309 citations · Full text

Medicine, Hematology, Oncology +16